Pricing and reimbursement of medicines: Commission consults on EU transparency rules

European CommissionThe European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites all interested parties to share their views on the review of Council Directive 89/105/EEC, often referred to as the 'transparency directive'. This directive has not been amended since 1989 despite substantial changes in the pharmaceutical market.

Although the prices of medicines and reimbursement are decided at national level, the Transparency Directive is aimed at facilitating the free movement of medicines in the EU.

The deadline for submitting contributions is 25 May 2011.

For further information, please visit: